Literature DB >> 9073543

The oral administration of low-dose antigen induces activation followed by tolerization, while high-dose antigen induces tolerance without activation.

T Yoshida1, S Hachimura, S Kaminogawa.   

Abstract

The systemic immune response and tolerance induced by oral administration of various doses of bovine alpha s1-casein were examined, focusing on cytokine responses in this study. Spleen cells from mice fed low doses of antigen secreted interferon-gamma and interleukin-2 in response to in vitro antigen stimulation, indicating that a Th1-type response was induced. In these mice, the Th1 responses after subsequent immunization and boosting with the antigen were diminished. In the case of mice fed high doses of the antigen, secretion of Th1 cytokines was minimal, but systemic responses after subsequent immunization and boosting with the antigen were strongly inhibited. Active suppression was not observed at any dose. The results indicate that, in this system, low-dose feeding induced activation of Th1 cells followed by tolerization, while high-dose feeding induced profound tolerance without prior activation. Our results have implications for clinical application of oral tolerance to allergy and autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9073543     DOI: 10.1006/clin.1996.4319

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  9 in total

1.  Effect of specific antigen stimulation on intraepithelial lymphocyte migration to small intestinal mucosa.

Authors:  S Komoto; S Miura; S Koseki; M Goto; S Hachimura; H Fujimori; R Hokari; Y Hara; T Ogino; C Watanabe; H Nagata; S Kaminogawa; T Hibi; H Ishii
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

2.  Interleukin 12 and CD86 Regulate Th1 and Th2 Development Induced by a Range of Antigen Doses Presented by Peyer's Patch and Spleen Cells.

Authors:  Tadashi Yoshida; Satoshi Hachimura; Mina Ishimori; Wataru Ise; Mamoru Totsuka; Akio Ametani; Shuichi Kaminogawa
Journal:  Cytotechnology       Date:  2003-11       Impact factor: 2.058

3.  Th2 polarization enhanced by oral administration of higher doses of antigen.

Authors:  M Hashiguchi; S Hachimura; A Ametani; S Kaminogawa
Journal:  Cytotechnology       Date:  2000-07       Impact factor: 2.058

4.  Changes in lamina propria dendritic cells on the oral administration of exogenous protein antigens during weaning.

Authors:  Ryuji Ohue; Masahiro Nakamoto; Naofumi Kitabatake; Fumito Tani
Journal:  Cytotechnology       Date:  2011-04-21       Impact factor: 2.058

Review 5.  Murine models for mucosal tolerance in allergy.

Authors:  Ursula Smole; Irma Schabussova; Winfried F Pickl; Ursula Wiedermann
Journal:  Semin Immunol       Date:  2017-08-12       Impact factor: 11.130

6.  Induction of T-cell activation or anergy determined by the combination of intensity and duration of T-cell receptor stimulation, and sequential induction in an individual cell.

Authors:  Tomohiro Yamamoto; Makoto Hattori; Tadashi Yoshida
Journal:  Immunology       Date:  2007-03-22       Impact factor: 7.397

7.  Complexities of applying nasal tolerance induction as a therapy for ongoing relapsing experimental autoimmune encephalomyelitis (EAE) in DA rats.

Authors:  X F Bai; H L Li; F D Shi; J Q Liu; B G Xiao; P H Van der Meide; H Link
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

8.  Feeding NOD mice with pig splenocytes induces transferable mechanisms that modulate cellular and humoral xenogeneic reactions against pig spleen or islet cells.

Authors:  S You; E Gouin; P Saï
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

9.  Critical role of intestinal interleukin-4 modulating regulatory T cells for desensitization, tolerance, and inflammation of food allergy.

Authors:  Haruyo Nakajima-Adachi; Kyoko Shibahara; Yoko Fujimura; Jun Takeyama; Erika Hiraide; Akira Kikuchi; Hitoshi Murakami; Akira Hosono; Tomonori Nochi; Yoshio Wakatsuki; Naoki Shimojo; Shuichi Kaminogawa; Ryuichiro Sato; Hiroshi Kiyono; Satoshi Hachimura
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.